MINGMING SU

MINGMING SU

University of Hawaii at Manoa

H-index: 47

North America-United States

About MINGMING SU

MINGMING SU, With an exceptional h-index of 47 and a recent h-index of 30 (since 2020), a distinguished researcher at University of Hawaii at Manoa, specializes in the field of Metabolomics, Cancer Research, Mass Spectrometry, translational metabolomics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Secondary bile acids improve risk prediction for non‐invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease

Norcholic acid: a novel biomarker of early kidney injury in patients with metabolic dysfunction-associated fatty liver disease

Untargeted metabolomics reveals gender-and age-independent metabolic changes of type 1 diabetes in Chinese children

Quantitative metabolomics reveals heart failure with midrange ejection fraction as a distinct phenotype of heart failure

Alterations of gut microbiome accelerate multiple myeloma progression by increasing the relative abundances of nitrogen-recycling bacteria

Experiments reveal abundance of nitrogen-recycling bacteria in patients with multiple myeloma

Urinary bile acid profile of newborns born by Cesarean section is characterized by oxidative metabolism of primary bile acids: limited roles of fetal-specific CYP3A7 in cholate …

Species differences of bile acid redox metabolism: tertiary oxidation of deoxycholate is conserved in preclinical animals

MINGMING SU Information

University

Position

University of Hawaii Cancer Center

Citations(all)

9102

Citations(since 2020)

4039

Cited By

6803

hIndex(all)

47

hIndex(since 2020)

30

i10Index(all)

81

i10Index(since 2020)

63

Email

University Profile Page

Google Scholar

MINGMING SU Skills & Research Interests

Metabolomics

Cancer Research

Mass Spectrometry

translational metabolomics

Top articles of MINGMING SU

Secondary bile acids improve risk prediction for non‐invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease

Alimentary pharmacology & therapeutics

2023/4

Norcholic acid: a novel biomarker of early kidney injury in patients with metabolic dysfunction-associated fatty liver disease

2023/4/28

Untargeted metabolomics reveals gender-and age-independent metabolic changes of type 1 diabetes in Chinese children

Frontiers in Endocrinology

2022/12/22

Quantitative metabolomics reveals heart failure with midrange ejection fraction as a distinct phenotype of heart failure

Canadian Journal of Cardiology

2021/2/1

Alterations of gut microbiome accelerate multiple myeloma progression by increasing the relative abundances of nitrogen-recycling bacteria

Blood

2019/11/13

Experiments reveal abundance of nitrogen-recycling bacteria in patients with multiple myeloma

2020/10/30

Urinary bile acid profile of newborns born by Cesarean section is characterized by oxidative metabolism of primary bile acids: limited roles of fetal-specific CYP3A7 in cholate …

Drug Metabolism and Disposition

2020/8/1

Species differences of bile acid redox metabolism: tertiary oxidation of deoxycholate is conserved in preclinical animals

Drug Metabolism and Disposition

2020/6/1

Urinary Bile Acids Profile of Cesarean Sectioned Newborns is Characterized by Oxidative Metabolism of Primary Bile Acids: Limited Roles of Fetal-specific CYP3A7 in Cholate …

Drug Metabolism and Disposition

2020/1/1

See List of Professors in MINGMING SU University(University of Hawaii at Manoa)